Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. September 2017 08:30 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience to Participate in U.S. Department of Energy Grant for Boosting Oilseed Yield in Camelina

WOBURN, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it will be a subawardee on a new U.S. Department of Energy (DOE) Grant to conduct...
05. September 2017 08:35 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience Obtains Confirmation of Nonregulated Status from USDA-APHIS for its Genome-edited Camelina Line

WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has received a positive response from USDA-APHIS’s Biotechnology Regulatory Services...
05. September 2017 08:30 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company focused on developing new technologies to achieve step-change improvements in crop yield to...
10. August 2017 16:05 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience Announces Second Quarter 2017 Financial Results

WOBURN, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three months ended June 30, 2017. “We made solid progress in the...
08. August 2017 09:00 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience Announces Collaboration with National Research Council of Canada to Improve Yield and Drought Tolerance in Wheat

WOBURN, Mass., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that its wholly owned Canadian subsidiary, Metabolix Oilseeds, Inc., has signed a...
27. Juli 2017 09:00 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience to Host Webcast of its Second Quarter 2017 Conference Call

WOBURN, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its second quarter 2017 financial results and host a...
03. Juli 2017 08:30 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience Announces Pricing of $2.3 Million Registered Direct Offering

WOBURN, Mass., July 03, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced that it has entered into a securities purchase agreement with certain new institutional...
27. Juni 2017 08:30 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience to Report Results Showing that Trait C4001 Produces Significant Increases in Plant Yield

WOBURN, Mass., June 27, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that the Company’s novel C4001 trait, a global regulatory gene or transcription factor, has been...
20. Juni 2017 09:00 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017

WOBURN, Mass., June 20, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CEO Oliver Peoples, Ph.D., will be presenting today at BIO 2017 on a panel entitled:...
15. Juni 2017 08:45 ET | Quelle: Yield10 Bioscience, Inc.

Yield10 Bioscience Submits “Am I Regulated?” Letter to USDA-APHIS BRS for Genome-Edited Camelina

WOBURN, Mass., June 15, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has submitted an “Am I Regulated?” letter to USDA-APHIS’s Biotechnology Regulatory...

Vorherige Seite